Stock RVNC REVANCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Revance Therapeutics, Inc.

Equities

RVNC

US7613301099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
3.32 USD -22.61% Intraday chart for Revance Therapeutics, Inc. -15.95% -62.23%
May. 10 Needham Adjusts Price Target on Revance Therapeutics to $12 From $18, Maintains Buy Rating MT
May. 10 Piper Sandler Cuts Price Target on Revance Therapeutics to $11 From $20, Maintains Overweight Rating MT
7b98f04104286c91a89730eb7f7b.28BEnkidstgAe9MGzNU-IdddixBFspmCJhYpmx574WY.l5Ac3yLI_rF5NJ1FtIVxRaYE_nh2wK_MQFRg9Sg8zBCNsi_xC8jIr2U6gg~46df82286e34c8a05f9d6f4eeb771ff1
  1. Stock Market
  2. Equities
  3. RVNC Stock
  4. Charts Revance Therapeutics, Inc.
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW